Drug:
Reaction: HOSPITALISATION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940164 |
EU |
1 | |
Hospitalisation, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 2 | 26940214 |
EU |
1 | |
Hospitalisation, Intentional product use issue, Adverse drug reaction, Skin toxicity, Off label use, |
||||
AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, |
||||
| 3 | 26940343 |
US |
2 | |
Hospitalisation, Visual impairment, |
||||
ABALOPARATIDE, |
||||
| 4 | 26940349 |
GB |
8 | 1 |
Hospitalisation, |
||||
SOMATROPIN, |
||||
| 5 | 26940649 |
US |
81 | 2 |
Hospitalisation, |
||||
| 6 | 26940651 |
JP |
||
Abdominal discomfort, Hospitalisation, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 7 | 26940845 |
US |
1 | |
Hospitalisation, |
||||
TIVOZANIB, |
||||
| 8 | 26940896 |
CA |
||
Hospitalisation, |
||||
AFLIBERCEPT, |
||||
| 9 | 26941473 |
JP |
64 | 2 |
Hospitalisation, Hyperglycaemia, Diabetes mellitus inadequate control, |
||||
EDARAVONE, EDARAVONE, |
||||
| 10 | 26941632 |
GB |
1 | |
Hospitalisation, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 11 | 26941749 |
US |
2 | |
Hospitalisation, Emergency care, Spinal pain, Musculoskeletal pain, Injection site pain, Product dose omission issue, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 12 | 26942043 |
US |
1 | |
Hospitalisation, Malaise, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 13 | 26942404 |
GB |
61 | |
Hospitalisation, |
||||
INFLIXIMAB-DYYB, |
||||
| 14 | 26942461 |
US |
||
Hospitalisation, Product use issue, |
||||
BOSENTAN, |
||||
| 15 | 26942611 |
CA |
74 | 1 |
Fatigue, Full blood count abnormal, Alanine aminotransferase abnormal, Dyspnoea, Hospitalisation, Asthma, Bronchiectasis, Cough, Therapeutic product effect incomplete, Rhinorrhoea, Sputum discoloured, Blood alkaline phosphatase abnormal, Chest pain, Lung opacity, |
||||
ITRACONAZOLE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, MEPOLIZUMAB, MEPOLIZUMAB, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LANSOPRAZOLE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, DEXLANSOPRAZOLE, LANSOPRAZOLE, PAROXETINE HYDROCHLORIDE, ITRACONAZOLE, BUPROPION HYDROCHLORIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, OMALIZUMAB, |
||||
| 16 | 26942671 |
US |
1 | |
Hospitalisation, Product prescribing issue, |
||||
OLUTASIDENIB, |
||||
| 17 | 26942979 |
US |
||
Hospitalisation, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 18 | 26943002 |
US |
60 | 1 |
Hospitalisation, |
||||
PEGLOTICASE, |
||||
| 19 | 26943370 |
US |
82 | 1 |
Hospitalisation, |
||||
ABATACEPT, |
||||
| 20 | 26943404 |
45 | 2 | |
Hospitalisation, |
||||
AMBRISENTAN, TADALAFIL, |
||||
| 21 | 26943427 |
2 | ||
Hospitalisation, |
||||
BELZUTIFAN, |
||||
| 22 | 26943725 |
EG |
72 | 2 |
Diarrhoea, Dehydration, Acidosis, Renal impairment, Vomiting, Hypertension, Hospitalisation, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, AMLODIPINE BESYLATE, LINAGLIPTIN, NEBIVOLOL HYDROCHLORIDE, INSULIN GLARGINE, |
||||
| 23 | 26943960 |
CA |
54 | 1 |
Hospitalisation, Intestinal operation, Chills, Pyrexia, Pain, |
||||
UPADACITINIB, |
||||
| 24 | 26944009 |
EU |
2 | |
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 25 | 26944033 |
US |
66 | 2 |
Hospitalisation, Hospitalisation, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, LIOTHYRONINE SODIUM, ESZOPICLONE, PYRIDOSTIGMINE BROMIDE, LEVOTHYROXINE SODIUM, IVABRADINE, ARIPIPRAZOLE, METOCLOPRAMIDE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE, ALPRAZOLAM, PRUCALOPRIDE, PREGABALIN, |
||||
| 26 | 26944064 |
US |
53 | 2 |
Death, Hospitalisation, |
||||
BOSENTAN, |
||||
| 27 | 26944346 |
US |
1 | |
Seizure, Product administration interrupted, Hospitalisation, Somnolence, Fatigue, Diarrhoea, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, CLOBAZAM, IRON, |
||||
| 28 | 26944460 |
US |
4 | 2 |
Urinary tract infection, Pneumonia, Oxygen saturation abnormal, Hospitalisation, Incorrect dose administered, |
||||
CANNABIDIOL, |
||||
| 29 | 26944642 |
US |
65 | 1 |
Hospitalisation, |
||||
| 30 | 26944659 |
CA |
63 | 2 |
Death, Hospitalisation, |
||||
ELAFIBRANOR, URSODIOL, URSOSIOL, CALCIUM, ESOMEPRAZOLE MAGNESIUM, TRIMETHOPRIM, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, |
||||
| 31 | 26944708 |
US |
2 | |
Hospitalisation, |
||||
SPARSENTAN, |
||||
| 32 | 26944783 |
US |
1 | |
Hospitalisation, Full blood count abnormal, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 33 | 26944809 |
US |
48 | 1 |
Hospitalisation, Liver disorder, Ammonia increased, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 34 | 26944949 |
US |
2 | |
Hospitalisation, Shoulder operation, Adverse drug reaction, Gastrointestinal disorder, Nausea, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 35 | 26945081 |
|||
Hospitalisation, |
||||
BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, |
||||
| 36 | 26945100 |
US |
2 | |
Hospitalisation, Joint stiffness, Condition aggravated, Tendon pain, Urine abnormality, Blood pressure increased, |
||||
ABALOPARATIDE, |
||||
| 37 | 26945116 |
US |
2 | |
Hospitalisation, Hypoacusis, Product dose omission issue, |
||||
ABALOPARATIDE, CALCIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIOTROPIUM BROMIDE AND OLODATEROL, |
||||
| 38 | 26945241 |
US |
29 | |
Hospitalisation, Device defective, Product dose omission issue, |
||||
DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, |
||||
| 39 | 26945893 |
US |
2 | |
Hospitalisation, Emergency care, Constipation, |
||||
ABALOPARATIDE, |
||||
| 40 | 26945924 |
US |
2 | |
Hospitalisation, Adverse event, Malaise, |
||||
ABALOPARATIDE, ABALOPARATIDE, CLONIDINE, |
||||
| 41 | 26946123 |
US |
17 | |
Hospitalisation, Product use issue, Product use issue, |
||||
CENOBAMATE, CENOBAMATE, |
||||
| 42 | 26946299 |
US |
2 | |
Hospitalisation, Confusional state, |
||||
ABALOPARATIDE, |
||||
| 43 | 26946400 |
US |
77 | 2 |
Hospitalisation, Gait disturbance, Therapy interrupted, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 44 | 26946456 |
US |
2 | |
Hospitalisation, Emergency care, Muscle spasms, |
||||
ABALOPARATIDE, |
||||
| 45 | 26946681 |
US |
84 | 2 |
Hospitalisation, Influenza, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 46 | 26946769 |
US |
2 | |
Hospitalisation, Condition aggravated, Pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ALBUTEROL SULFATE, APREPITANT, DULOXETINE HYDROCHLORIDE, DULOXETINE, FOLIC ACID, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, INSULIN GLARGINE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, METHOTREXATE, METHOTREXATE SODIUM, INSULIN ASPART, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PREGABALIN, ADALIMUMAB-RYVK, TOPIRAMATE, |
||||
| 47 | 26946785 |
US |
75 | 2 |
Hospitalisation, Fall, |
||||
ABALOPARATIDE, |
||||
| 48 | 26947156 |
US |
2 | |
Hospitalisation, Bone density abnormal, Fall, Back pain, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 49 | 26947341 |
US |
2 | |
Hospitalisation, Emergency care, Product use in unapproved indication, |
||||
ABALOPARATIDE, |
||||
| 50 | 26947561 |
US |
71 | 2 |
Hospitalisation, Benign neoplasm, Product use in unapproved indication, |
||||
ABALOPARATIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, LEFLUNOMIDE, |
||||
| 51 | 26947619 |
US |
2 | |
Hospitalisation, Emergency care, Joint swelling, Arthralgia, Drug ineffective, |
||||
ABALOPARATIDE, ETANERCEPT, |
||||
| 52 | 26947674 |
US |
2 | |
Hospitalisation, Crystal urine present, |
||||
ABALOPARATIDE, CALCIUM, |
||||
| 53 | 26947710 |
US |
2 | |
Hospitalisation, Mood swings, Emergency care, |
||||
ABALOPARATIDE, |
||||
| 54 | 26948040 |
GB |
82 | |
Hospitalisation, Back pain, Condition aggravated, Blood disorder, Fatigue, Myalgia, Flushing, Localised infection, Incorrect dose administered by device, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 55 | 26948088 |
US |
35 | 2 |
Hospitalisation, Emergency care, Product use issue, |
||||
ABALOPARATIDE, TEZEPELUMAB-EKKO, |
||||
| 56 | 26948138 |
US |
2 | |
Hospitalisation, Peripheral swelling, Emergency care, |
||||
ABALOPARATIDE, |
||||
| 57 | 26951163 |
2 | ||
Pain, Intentional dose omission, Hospitalisation, |
||||
UPADACITINIB, ATORVASTATIN CALCIUM, |
||||
| 58 | 26951658 |
56 | 2 | |
Hospitalisation, |
||||
TRETINOIN, |
||||
| 59 | 26951798 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
MOMELOTINIB, |
||||
| 60 | 26951802 |
|||
Hospitalisation, |
||||
PAROXETINE HYDROCHLORIDE, MONTELUKAST, |
||||
| 61 | 26951803 |
|||
Hospitalisation, |
||||
PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
| 62 | 26951856 |
47 | 2 | |
Hospitalisation, |
||||
AVACOPAN, |
||||
| 63 | 26952109 |
|||
Hospitalisation, |
||||
INCOBOTULINUMTOXINA, |
||||
| 64 | 26952196 |
|||
Hospitalisation, |
||||
GABAPENTIN, |
||||
| 65 | 26952201 |
|||
Hospitalisation, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 66 | 26952202 |
|||
Hospitalisation, |
||||
NITROGLYCERIN, |
||||
| 67 | 26967534 |
65 | 1 | |
Hospitalisation, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 68 | 26934104 |
US |
1 | |
Dyspnoea, Cardiac disorder, Hospitalisation, |
||||
MEPOLIZUMAB, |
||||
| 69 | 26934551 |
US |
||
Hospitalisation, |
||||
SELEXIPAG, |
||||
| 70 | 26934559 |
CA |
2 | |
Hospitalisation, Product dose omission issue, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 71 | 26934703 |
US |
2 | |
Hospitalisation, |
||||
ETANERCEPT, |
||||
| 72 | 26934882 |
US |
||
Hospitalisation, Mania, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 73 | 26934934 |
JP |
25 | 1 |
Hospitalisation, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 74 | 26935027 |
US |
65 | 2 |
Hospitalisation, |
||||
RIFAXIMIN, |
||||
| 75 | 26935033 |
US |
85 | |
Hospitalisation, Therapy interrupted, Pain, Pain, Pain, Flank pain, Nausea, Flank pain, Nausea, Vomiting, Incorrect dose administered, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 76 | 26935061 |
GB |
80 | 2 |
Hospitalisation, Blood test abnormal, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 77 | 26935082 |
KR |
2 | |
Hospitalisation, Red blood cell transfusion, Red blood cell transfusion, Radiotherapy, Inappropriate schedule of product administration, Inappropriate schedule of product administration, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 78 | 26935407 |
US |
2 | |
Hospitalisation, |
||||
ORAL SEMAGLUTIDE, |
||||
| 79 | 26935675 |
CN |
1 | |
Hospitalisation, |
||||
| 80 | 26935810 |
US |
2 | |
Hospitalisation, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 81 | 26935859 |
US |
56 | 2 |
Hospitalisation, |
||||
PANITUMUMAB, PANITUMUMAB, |
||||
| 82 | 26935881 |
US |
||
Hospitalisation, |
||||
SELEXIPAG, |
||||
| 83 | 26936208 |
CA |
61 | |
Hospitalisation, |
||||
AFLIBERCEPT, |
||||
| 84 | 26936249 |
GB |
87 | 2 |
Hospitalisation, |
||||
DARBEPOETIN ALFA, RUXOLITINIB, RUXOLITINIB, |
||||
| 85 | 26936263 |
US |
2 | |
Hospitalisation, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, PHENOBARBITAL, LEVETIRACETAM, CLOBAZAM, CLONIDINE HYDROCHLORIDE, |
||||
| 86 | 26936549 |
US |
2 | |
Hospitalisation, |
||||
ETANERCEPT, |
||||
| 87 | 26936556 |
EU |
39 | 1 |
Hospitalisation, |
||||
PEGFILGRASTIM, AZATHIOPRINE, MESALAMINE, URSODIOL, URSOSIOL, |
||||
| 88 | 26936587 |
US |
45 | 2 |
Hospitalisation, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, |
||||
| 89 | 26936660 |
CA |
14 | 2 |
Hospitalisation, |
||||
CANNABIDIOL, |
||||
| 90 | 26936929 |
CA |
||
Hospitalisation, |
||||
AFLIBERCEPT, |
||||
| 91 | 26936986 |
US |
38 | 1 |
Hospitalisation, |
||||
| 92 | 26937069 |
US |
64 | 2 |
Hospitalisation, Heart rate irregular, White blood cell count decreased, Red blood cell count decreased, Off label use, Off label use, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, DECITABINE, ISAVUCONAZONIUM SULFATE, ACYCLOVIR, LOSARTAN, |
||||
| 93 | 26937131 |
US |
20 | 1 |
Syncope, Hospitalisation, |
||||
RIOCIGUAT, RIOCIGUAT, SOTATERCEPT-CSRK, SELEXIPAG, |
||||
| 94 | 26937404 |
US |
||
Hospitalisation, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 95 | 26937435 |
US |
77 | |
Death, Hospitalisation, |
||||
VUTRISIRAN, VUTRISIRAN, FUROSEMIDE, ROSUVASTATIN, TAFAMIDIS, |
||||
| 96 | 26937773 |
US |
2 | |
Hospitalisation, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 97 | 26937850 |
US |
2 | |
Hospitalisation, Off label use, |
||||
CANNABIDIOL, |
||||
| 98 | 26937969 |
2 | ||
Hospitalisation, |
||||
ONABOTULINUMTOXINA, FREMANEZUMAB-VFRM, LORAZEPAM, GABAPENTIN, EMPAGLIFLOZIN, MODAFINIL, PANTOPRAZOLE SODIUM, SOTALOL HYDROCHLORIDE TABLES AF, SOTALOL HYDROCHLORIDE TABLETS AF, |
||||
| 99 | 26938066 |
GB |
2 | |
Hospitalisation, Off label use, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 100 | 26938122 |
US |
54 | 2 |
Hospitalisation, |
||||
ADAGRASIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30